During the past decade, DIA- Kontrol s.r.o. conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "DIA- Kontrol s.r.o." #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "DIA- Kontrol s.r.o." are "Diabetes Mellitus, Type 2" (1 trials), "Dyslipidemia" (1 trials) and "Type2 Diabetes" (1 trials). Many other conditions were trialed in "DIA- Kontrol s.r.o." in a lesser frequency.

Most popular intervention types in "DIA- Kontrol s.r.o." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "K-877" (1 trials), "Placebo" (1 trials), "glimepiride" (1 trials), "glimepiride placebo" (1 trials) and "linagliptin" (1 trials). Other intervention names were less common.

The vast majority of trials in "DIA- Kontrol s.r.o." are 2 trials for "All" genders.

Currently, there are NaN active trials in "DIA- Kontrol s.r.o.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in DIA- Kontrol s.r.o., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in DIA- Kontrol s.r.o., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".